Maternal Psychosocial Stress, COVID-19 Infection Tied to Infant Attentional Processing
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 3, 2023 -- Maternal psychosocial stress and COVID-19 infection during pregnancy may have joint effects on infant attention at six months, according to a study published online Sept. 27 in Pediatric Research.
Denise M. Werchan, Ph.D., from New York University Langone in New York City, and colleagues examined the joint effects of maternal psychosocial stress and COVID-19 infection during pregnancy on infant attention at six months postpartum. The analysis included 167 pregnant mother-infant dyads (50 with COVID-19).
The researchers found that maternal psychosocial stress and COVID-19 infection during pregnancy jointly predicted infant attention at six months. Higher prenatal psychosocial stress was associated with lower infant attention at six months only among mothers reporting positive COVID-19 infection. In turn, infant attention predicted socioemotional function and neurodevelopmental risk at 12 months.
"This study found that elevated maternal psychosocial stress and COVID-19 infection during pregnancy jointly predicted lower infant attention scores at six months, which is a known marker of risk for neurodevelopmental disorder. In turn, infant attention predicted socioemotional function and risk for neurodevelopmental disorder at 12 months," the authors write. "These data suggest that maternal psychosocial stress may modulate the effects of gestational infection on neurodevelopment and highlight malleable targets for intervention."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Further Support and Information on COVID-19
Read this next
Residual Risk Seen for Death, Postacute Sequelae in Third Year After COVID-19 Hospitalization
THURSDAY, June 13, 2024 -- For individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the risks for death and postacute sequelae of COVID-19...
Systemic Side Effects of COVID-19 Vaccine Tied to Greater nAB Response
TUESDAY, June 11, 2024 -- Short-term systemic side effects of the severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA vaccine are associated with greater long-lasting...
Nirmatrelvir-Ritonavir No Aid for Long COVID Symptoms
MONDAY, June 10, 2024 -- A 15-day course of nirmatrelvir-ritonavir (NMV/r) is safe but does not demonstrate a significant benefit for improving postacute sequelae of SARS-CoV-2...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.